Page last updated: 2024-11-01

nomifensine and Adrenal Cancer

nomifensine has been researched along with Adrenal Cancer in 1 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naoi, M1
Takahashi, T1
Ichinose, H1
Wakabayashi, K1
Sugimura, T1
Nagatsu, T1

Other Studies

1 other study available for nomifensine and Adrenal Cancer

ArticleYear
Uptake of heterocyclic amines, Trp-P-1 and Trp-P-2, into clonal rat pheochromocytoma PC12h cells by dopamine uptake system.
    Neuroscience letters, 1989, May-08, Volume: 99, Issue:3

    Topics: Adrenal Gland Neoplasms; Animals; Carbolines; Chromatography, High Pressure Liquid; Dopamine; Kineti

1989